Dkbmed Radio

The advent of triple CFTR modulator therapy – ETI (elexacaftor/tezacaftor/ivacaftor) — poses a number of clinical questions. Are three agents really better than two? For which patients, in what circumstances? What does the CF Team need to understand to ensure their patients get maximum benefit? Join us as we explore these questions with guest author Professor Edward McKone MD, from St. Vincent’s University Hospital and University College Dublin School of Medicine, in this eCysticFibrosis Review podcast. Take our post-test to claim CME credits.Read this podcast's companion newsletter here. Hosted on Acast. See acast.com/privacy for more information.

Most people living with HIV gain weight when initiating ART. For some, the weight gain signifies a “return to health”; for others, the additional weight can be clinically significant and may be strongly associated with an increased risk of metabolic abnormalities. What causes this weight gain? How can patients most at risk for weight-related comorbidities be identified? Join us as we discuss these and other issues with Dr. Todd Brown, Professor of Medicine and Epidemiology at Johns Hopkins University, in this eHIV Review podcast. Take our post-test to claim CME credits.To read a companion newsletter click here. Hosted on Acast. See acast.com/privacy for more information.

Where’s the newer MS research leading? How has our understanding of noninflammatory progressive MS changed? How might these findings affect what happens in the clinic? Join us as we discuss these and other questions with Dr. Michael Kornberg from the Johns Hopkins School of Medicine in this eMultipleSclerosis Review podcast. Take our post-test to claim CME credits.To read a companion newsletter click here. Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.

Dr. Paul Auwaerter interviews Dr. Michael Mina about COVID-19 testing. Topics: *Why are we seeing prolonged antigen positive test results? *Do we know when someone is infectious? For how long? *Speculating on the cause of Paxlovid rebound Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/7-28-22-episode/eval  Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty Presenting faculty:  Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine Michael Mina, MD, PhD, Chief Science Officer, eMed, Epidemiologist, Immunologist and Physician  Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.

Dr. Paul Auwaerter interviews Dr. Michael Mina about COVID-19 immunity. Topics: *Is COVID-19 here to stay? *Immunity evasiveness of Omicron BA.4 and BA.5 *Expectations for the fall and winter 2022 *Thoughts on upcoming booster reformulation *Should you get a booster now or wait? Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/7-28-22-episode/eval  Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty Presenting faculty:  Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine Michael Mina, MD, PhD, Chief Science Officer, eMed, Epidemiologist, Immunologist and Physician  See acast.com/privacy for privacy and opt-out information.

Is it true that a significant number of patients being treated for MS may not actually have the disease? What are the red flags — warnings that something about the patient’s condition does not meet the accepted MS diagnostic criteria — that need to be investigated?   Join us in this eMultipleSclerosis Review podcast, as Neuroimmunologist Dr. Gabrielle Macaron from Saint Joseph University’s Hotel Dieu de France Hospital in Beirut, Lebanon, and the Cleveland Clinic’s Mellen Center for Multiple Sclerosis, explains strategies to reduce misdiagnosis of MS. Take our post-test to claim CME credits.To read a companion newsletter click here. See acast.com/privacy for privacy and opt-out information.

In this Issue: Fatigue. Urinary dysfunction. Constipation. Spasticity and gait problems. Providing relief from these common MS symptoms often requires clinicians to go beyond the prescription pad to recommend nonpharmacologic treatments. What works? What doesn’t? What does the evidence say? Join us as Dr. W. Oliver Tobin from the Mayo Clinic discusses these questions in this eMultipleSclerosis Review podcast.Take our post-test to claim CME credits.To read a companion newsletter click here. See acast.com/privacy for privacy and opt-out information.

Are PLWH at higher risk for increased mortality from COVID-19 infection? How important is it for PWLH to get vaccinated and boosted? Is breakthrough COVID-19 infection more likely to occur among PLWH? What about “long COVID” (PASC)?Join Clinical Research Nurse Diane Kanjilal, manager of the Infectious Disease Clinical Research Unit at Massachusetts General Hospital, as we discuss these questions in this eHIV Review podcast.Take our post-test to claim CME credits.To read a companion newsletter click here. See acast.com/privacy for privacy and opt-out information.

What was it like for a frontline critical care pulmonologist at the very beginning of the COVID-19 epidemic? On the frontlines as the epidemic became pandemic? What’s it like today, with new variants and new in-patient and out-patient treatments? What are the key differences between then and now, what have we learned, and how can we be better prepared for next time? Join us for this ePulmonology Review Special Edition podcast, as Dr. Brian Garibaldi from the Johns Hopkins’ Division of Pulmonary and Critical Care Medicine takes us through his experiences battling COVID 19: Then and Now. Take our post-test to claim CME credits. See acast.com/privacy for privacy and opt-out information.

Managing pulmonary exacerbations in people with cystic fibrosis: is there high-grade evidence to support best practices? How helpful is the most current guidance? Does the recent research challenge the current standard of care?  Join us for this eCysticFibrosis Review podcast, as Dr. D.B. Sanders from the Indiana University School of Medicine explains how these questions can affect clinical care. Take our post-test to claim CME credits.Read this podcast's companion newsletter here. See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter discusses COVID-19 vaccine boosters. Topics: *Should your patients get the booster now or wait? *FDA advisory committee votes to include Omicron component in COVID-19 booster vaccines *COVID-19 case and mortality projections for this winter *Booster timing for children and adults Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/7-6-22-episode/eval  Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty Presenting faculty:  Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  See acast.com/privacy for privacy and opt-out information.

Race and ethnicity. How do they affect a patient’s ability to receive a timely and accurate cystic fibrosis diagnosis? How do the social determinants of health limit access to appropriate CF treatment and produce poorer outcomes? That’s what we’re here to talk about today with Dr. Jennifer Taylor-Cousar from National Jewish Health and Children’s Hospital Colorado in this eCysticFibrosis Review podcast. Take our post-test to claim CME credits.Read this podcast's companion newsletter here. See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter discusses the current state of COVID-19 including treatment updates. Topics: *Information on new Omicron subvariants *CDC advisory about rebound COVID-19 *Latest treatment information *Post-COVID conditions Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/6-1-22-episode/eval  Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty Presenting faculty:  Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter discusses the effect of the Omicron variant, including its subvariants, on COVID-19 vaccines. Topics: *Impact of Omicron on mRNA boosters *Analyzing Omicron and BA.2 subvariants *Interpreting CDC vaccine data *Protection level of one-way masking Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/5-11-22-episode/eval  Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty Presenting faculty:  Paul Auwaerter, MD, MBA, FIDSA, Clinical Director, Division of Infectious Diseases, Sherrilyn and Ken Fisher Professor of Medicine, Fisher Center for Environmental Infectious Diseases, Johns Hopkins University School of Medicine  See acast.com/privacy for privacy and opt-out information.

Paul G. Auwaerter, MD, MBA, FIDSA and Michael Angarone, DO, FIDSA discuss the latest guidelines for prevention of COVID-19. Topics: *Updates on the BA.2 subvariant *Who should get a second booster? And when? *What conditions and factors place people at higher risk for severe COVID? *Pre-exposure prophylaxis for COVID-19 prevention *Mitigating risk of disease progression  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/4-26-22-episode/eval  Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  Presenting faculty:  Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Sherrilyn and Ken Fisher Professor of Medicine at Johns Hopkins University School of Medicine   Michael Angarone, DO, FIDSA, Associate Professor, Division of Infectious Diseases, Departments of Medicine and Medical Education at Northwestern University Feinberg

Paul G. Auwaerter, MD, MBA, FIDSA and David Klimpl, MD discuss current treatments for patients hospitalized with COVID-19. Topics: *New data on efficacy of available therapies *Immunomodulators for critical care patients *Updated NIH recommendations  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/4-6-22-episode/eval  Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty Presenting faculty:  Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Sherrilyn and Ken Fisher Professor of Medicine at Johns Hopkins University School of Medicine  David Klimpl, MD, Assistant Professor at University of Colorado Denver – Anschutz Medical Campus   See acast.com/privacy for privacy and opt-out information.

Long-acting injectable antiretroviral therapy is expected to improve adherence, reduce patient burden, and lower community viral load. But for which patients is it suitable? Can it be used as pre-exposure prophylaxis? How does the promise of long-acting ART actually mean in practice?</p><p>Join us for this <em>e</em>HIV Review podcast, as Dr. Tanyaporn Wansom, Senior Infectious Diseases Consultant at Chayun Consulting in Bangkok Thailand, takes us to the clinic to answer some of these key questionsTake our post-test to claim CME credits.To read a companion newsletter click here. See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter discusses new vaccine boosters, global impact of the pandemic, and the BA.2 Subvariant. Topics: *New boosters in the future? *Challenges of additional boosters *Cardiac concerns with COVID-19 vaccines? *Collateral effects from the pandemic *Latest news on BA.2 Subvariant Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/4-13-22-episode/eval  Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty Presenting faculty:  Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter discusses the BA.2 Subvariant and the recent authorization from the FDA for second booster dose. Topics: *Virulence of BA.2 vs Omicron and Delta * Therapeutic activity of monoclonal antibodies against BA.2 *Details of approval for booster #2 (4th and 5th dose) *Are there advantages to mixing mRNA vaccines? Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-30-22-episode/eval  Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty Presenting faculty:  Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter discusses what we learned from the COVID-19 pandemic. Topics: *Reviewing the timeline of events and variants *What happens next? *Preparing for the future *The new role of monoclonal antibodies Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-24-22-episode/eval  Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty Presenting faculty:  Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  See acast.com/privacy for privacy and opt-out information.